Karpas-299
Copy the product info.
Cat. No.: CL-0807
-
-
-
- +2
CL-0807
$ 500.00
Select a size
1×10^6Cells/Vial×2Vials
Quantity
-
+
In stock
InquireFor order requirements and technical needs, please Contact Us
Product Introduction
General information
| Cell Name | Karpas-299 |
| Synonyms | KARPAS-299;Karpas 299;KARPAS 299;Karpas299;KARPAS299;K299 |
| Cellosaurus Accession | CVCL_1324 |
| Organism | Human |
| Growth Properties | Suspension |
| Morphology | Lymphoblast-like |
| Disease | lymphoma cells |
| Tissue | Peripheral blood |
| Age | 25Y |
| Sex | Male |
Handling information
| Instructions | 1. Check all containers for leakage or breakage. 2. Remove the frozen cells from the dry ice packaging and immediately transfer them to liquid nitrogen (liquid or vapor phase) for long-term cryopreservation. |
| Complete Medium | RPMI-1640 [PM150110]+10% Nutrient+1% Supplement |
| Incubation Atmosphere | Air, 95%; CO₂, 5% |
| Temperature | 37℃ |
| Subcultivation Ratio | 1:2-1:4 |
| Medium Renewal | 2 to 3 times per week |
| Subculturing Procedure | Cultures can be maintained by either supplementing with fresh medium or exchanging medium via centrifugation. The recommended centrifugation conditions are 1200 rpm (approximately 250 × g) for 3 minutes. |
| Freeze Medium | 90% FBS+10% DMSO |
| Storage Conditions | For long-term cryopreservation, cryovials should be stored in liquid nitrogen at −150°C to −196°C. Storage at −80°C is restricted to short-term interim use only. |
Reference materials
| Background | Karpas-299 is a human T-cell lymphoma cell line established in 1986 from peripheral blood collected from a 25-year-old male patient diagnosed with T-cell non-Hodgkin’s lymphoma. The cell line is now pathologically classified as CD30-positive anaplastic large cell lymphoma (ALCL) and harbors the characteristic NPM-ALK fusion oncogene. |
| Biosafety Level | BSL-2 |
MSDS
